Eledon Pharmaceuticals, Inc.
ELDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404281
No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.9M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Eledon Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Eledon Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Gros David-Alexandre C | Chief Executive Officer | 168,663 | Aug 4, 2026 | 1 |
| Perrin Steven | President | 81,215 | Aug 4, 2026 | 1 |
| Katkin Keith | Director | 8,575 | Jan 16, 2026 | 1 |
| McBride John S. | Director | 3,430 | Jan 16, 2026 | 1 |
| Lee June | Director | 3,430 | Jan 16, 2026 | 1 |
| Robinson James A. Jr. | Director | 3,430 | Jan 16, 2026 | 1 |
| Hillson Jan | Director | 3,430 | Jan 16, 2026 | 1 |
| Kirk Allan | Director | 3,430 | Jan 16, 2026 | 1 |
| Smith Bryan E. | General Counsel, Corporate Sec | – | Jan 13, 2025 | 0 |
| Little Paul Sean | Chief Financial Officer | – | Jan 13, 2025 | 0 |
| Biotechnology Value Fund L P | Other: See Explanation of Responses | 220,460 | Oct 31, 2024 | 0 |
| BVF Partners L P | 10% Owner | 220,460 | Oct 31, 2024 | 0 |
| BVF Inc | 10% Owner | 220,460 | Oct 31, 2024 | 0 |
| Biotechnology Value Fund II LP | Other: See Explanation of Responses | 220,460 | Oct 31, 2024 | 0 |
| Lampert Mark N | 10% Owner | 220,460 | Oct 31, 2024 | 0 |
| Biotechnology Value Trading Fund OS LP | Other: See Explanation of Responses | 220,460 | Oct 31, 2024 | 0 |
| BVF Partners OS Ltd. | Other: See Explanation of Responses | 220,460 | Oct 31, 2024 | 0 |
| BVF I GP LLC | Other: See Explanation of Responses | 220,460 | Oct 31, 2024 | 0 |
| BVF II GP LLC | Other: See Explanation of Responses | 220,460 | Oct 31, 2024 | 0 |
| BVF GP Holdings LLC | 10% Owner | 220,460 | Oct 31, 2024 | 0 |
| Lyons Gary A | Director | – | May 2, 2023 | 0 |
| Ogier Walter C | Director | – | May 2, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 31, 2024 (view filing)5:52 PM ET | Oct 29 | 2 days | Biotechnology Value Fund L P and 9 othersOther: See Explanation of Responses | PPurchaseCommon Stock, $0.001 par value | +4.75M | $3.65 | +$17.3M | –838.5K after | Derivative3 lots |
| May 13, 2024 (view filing)5:04 PM ET | May 9 | 4 days | Biotechnology Value Fund L P and 9 othersOther: See Explanation of Responses | PPurchaseCommon Stock, $0.001 par value | +1.93M | – | – | New position220.5K after | 3 lots |
| May 13, 2024 (view filing)5:04 PM ET | May 9 | 4 days | Biotechnology Value Fund L P and 9 othersOther: See Explanation of Responses | PPurchaseCommon Stock, $0.001 par value | +5.93M | – | – | –232.1K after | Derivative3 lots |
| May 9, 2023 (view filing)8:25 PM ET | May 5 | 4 days | Biotechnology Value Fund L P and 9 othersOther: See Explanation of Responses | PPurchaseCommon Stock, $0.001 par value | +1.98M | – | – | New position145.0K after | 3 lots |
| May 9, 2023 (view filing)8:25 PM ET | May 5 | 4 days | Biotechnology Value Fund L P and 9 othersOther: See Explanation of Responses | PPurchaseCommon Stock, $0.001 par value | +9.59M | – | – | –252.3K after | Derivative6 lots |
| Nov 23, 2022 (view filing) | Nov 23 | Same day | Perrin StevenPresident | PPurchase | +1.00K | $2.60 | +$2.60K | New position1.00K after | |
| Dec 21, 2021 (view filing) | Dec 20 | 1 day | Gros David-Alexandre CChief Executive Officer | PPurchase | +2.00K | $4.48 | +$8.96K | +28.6%9.00K after | |
| Aug 19, 2021 (view filing) | Aug 17 | 2 days | Gros David-Alexandre CChief Executive Officer | PPurchase | +4.00K | $6.21 | +$24.8K | +133.3%7.00K after |